No Detail Found!

Comparative study of efficacy of topical anthralin (0.5%) and topical calcipotriol (0.005%) in management of chronic plaque psoriasis

Author(s)
Safoora Naveed Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi, Pakistan
Asher Ahmed Mashhood Department of Dermatology, Combined Military Hospital, Rawalpindi. Pakistan
Sakina Sadiq Malik Department of Dermatology, Combined Military Hospital, Rawalpindi. Pakistan
Abrar Ahmad Khalid Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi. Pakistan
Muhammad Anjum Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi. Pakistan
Ayesha Ellahi Department of Pathology, Army Medical College, Rawalpindi. Pakistan
Zafar Iqbal Shaikh Department of Dermatology, Pak Emirates Military Hospital, Rawalpindi Pakistan
Abstract
Objective The aim of the study is to compare the efficacy of topical calcipotriol (0.005%) and topical anthralin (0.5%) in treatment of Chronic Plaque Psoriasis (CPP). Methods This randomized, interventional study was conducted at Pak Emirates Military Hospital, Rawalpindi and Combined Military Hospital, Rawalpindi for 6-month period (10th January 2020 to 10th July 2020). A sample of 186 patients was randomly distributed in two groups. In group A, patients applied topical anthralin (0.5%) every night for 12 weeks. In group B, patients applied topical calcipotriol (0.005%) every night for 12 weeks. The follow up period was 12 weeks and assessment of the efficacy was done at 4, 8 and 12 weeks by utilizing PASI score. Results The age range of the individuals was from 15 to 50 years. The average duration of presenting complaint for Group A was 8.903±1.85 months while for Group B was 9.193±2.58 months. In Group A, the average PASI score before and after the treatment was 16.22±3.02 and 4.784±3.28 respectively and in Group B the average PASI score before and after the treatment was 16.03±2.09 and 2.376±2.39 respectively. The number of male patients in each group was more than female. Efficacy i.e. reduction in PASI score by 75% was seen in 21.5% patients of Group A as compared to 43% in Group B (p=0.001). Conclusion In conclusion, 0.005% calcipotriol is considerably more efficacious than 0.5% anthraline in bringing disease improvement and patient satisfaction than 0.5% anthraline.
Publication Details
Page(s) 827-831
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 33, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Efficacy, Anthraline, calcipotriol, Chronic plaque psoriasis
0

Citations

0

Downloads

132

Views